FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3148102859> ?p ?o ?g. }

• W3148102859 endingPage "1354" @default.
• W3148102859 startingPage "1346" @default.
• W3148102859 abstract "Cytomegalovirus (CMV) reactivation is one of the most common infectious complications after allogeneic hematopoietic cell transplant (HCT) and may result in significant morbidity and mortality. Primary prophylaxis with letermovir demonstrated a reduction in clinically significant CMV infections (CS-CMVi) in clinical trials of CMV-seropositive HCT recipients. This study aims at exploring the effect of primary letermovir prophylaxis in this population on the incidence and outcomes of refractory or resistant CMV infections.This is a single-center, retrospective cohort study of 537 consecutive CMV-seropositive allogeneic HCT recipients cared for between March 2016 and October 2018. Baseline demographics, HCT characteristics, CMV infections, treatment, and mortality data were collected from the electronic medical record. CMV outcomes were defined according to the recently standardized definitions for clinical trials. Characteristics and outcomes were assessed according to receipt of primary letermovir prophylaxis.Of 537 patients identified, 123 received letermovir for primary prophylaxis during the first 100 days after HCT; 414 did not. In a multivariate analysis, primary prophylaxis with letermovir was associated with reductions in CS-CMVi (hazard ratio [HR] 0.26; 95% confidence interval [CI], 0.16-0.41), CMV end-organ disease (HR 0.23; 95% CI, 0.10-0.52), refractory or resistant CMV infection (HR 0.15; 95% CI, 0.04-0.52), and nonrelapse mortality at week 48 (HR 0.55; 95% CI, 0.32-0.93). There was neither resistant CMV nor CMV-related mortality in the primary letermovir prophylaxis group.Primary letermovir prophylaxis effectively prevents refractory or resistant CMV infections and decreases nonrelapse mortality at week 48, as well as CS-CMVi and CMV disease after allogeneic HCT." @default.
• W3148102859 created "2021-04-13" @default.
• W3148102859 creator A5003181387 @default.
• W3148102859 creator A5007730121 @default.
• W3148102859 creator A5026334708 @default.
• W3148102859 creator A5026385665 @default.
• W3148102859 creator A5029454216 @default.
• W3148102859 creator A5035144349 @default.
• W3148102859 creator A5041781576 @default.
• W3148102859 creator A5048913229 @default.
• W3148102859 creator A5055885795 @default.
• W3148102859 creator A5062028073 @default.
• W3148102859 creator A5065590894 @default.
• W3148102859 creator A5091663701 @default.
• W3148102859 date "2021-04-08" @default.
• W3148102859 modified "2023-10-01" @default.
• W3148102859 title "Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era" @default.
• W3148102859 cites W2007491768 @default.
• W3148102859 cites W2046433603 @default.
• W3148102859 cites W2056522147 @default.
• W3148102859 cites W2070725742 @default.
• W3148102859 cites W2119962983 @default.
• W3148102859 cites W2126489948 @default.
• W3148102859 cites W2131091524 @default.
• W3148102859 cites W2141200873 @default.
• W3148102859 cites W2145493091 @default.
• W3148102859 cites W2148832620 @default.
• W3148102859 cites W2161055538 @default.
• W3148102859 cites W2161600613 @default.
• W3148102859 cites W2277663056 @default.
• W3148102859 cites W2501406433 @default.
• W3148102859 cites W2524753328 @default.
• W3148102859 cites W2533435998 @default.
• W3148102859 cites W2771598353 @default.
• W3148102859 cites W2888202523 @default.
• W3148102859 cites W2894957709 @default.
• W3148102859 cites W2949417789 @default.
• W3148102859 cites W2975880906 @default.
• W3148102859 cites W2977630397 @default.
• W3148102859 cites W2982355986 @default.
• W3148102859 cites W3008607427 @default.
• W3148102859 cites W3014808921 @default.
• W3148102859 cites W3041047511 @default.
• W3148102859 cites W3089579759 @default.
• W3148102859 cites W3092010118 @default.
• W3148102859 doi "https://doi.org/10.1093/cid/ciab298" @default.
• W3148102859 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8528390" @default.
• W3148102859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33830182" @default.
• W3148102859 hasPublicationYear "2021" @default.
• W3148102859 type Work @default.
• W3148102859 sameAs 3148102859 @default.
• W3148102859 citedByCount "32" @default.
• W3148102859 countsByYear W31481028592021 @default.
• W3148102859 countsByYear W31481028592022 @default.
• W3148102859 countsByYear W31481028592023 @default.
• W3148102859 crossrefType "journal-article" @default.
• W3148102859 hasAuthorship W3148102859A5003181387 @default.
• W3148102859 hasAuthorship W3148102859A5007730121 @default.
• W3148102859 hasAuthorship W3148102859A5026334708 @default.
• W3148102859 hasAuthorship W3148102859A5026385665 @default.
• W3148102859 hasAuthorship W3148102859A5029454216 @default.
• W3148102859 hasAuthorship W3148102859A5035144349 @default.
• W3148102859 hasAuthorship W3148102859A5041781576 @default.
• W3148102859 hasAuthorship W3148102859A5048913229 @default.
• W3148102859 hasAuthorship W3148102859A5055885795 @default.
• W3148102859 hasAuthorship W3148102859A5062028073 @default.
• W3148102859 hasAuthorship W3148102859A5065590894 @default.
• W3148102859 hasAuthorship W3148102859A5091663701 @default.
• W3148102859 hasBestOaLocation W31481028592 @default.
• W3148102859 hasConcept C121332964 @default.
• W3148102859 hasConcept C126322002 @default.
• W3148102859 hasConcept C142424586 @default.
• W3148102859 hasConcept C167135981 @default.
• W3148102859 hasConcept C203014093 @default.
• W3148102859 hasConcept C207103383 @default.
• W3148102859 hasConcept C2776409557 @default.
• W3148102859 hasConcept C2777732132 @default.
• W3148102859 hasConcept C2780727368 @default.
• W3148102859 hasConcept C2908647359 @default.
• W3148102859 hasConcept C3013748606 @default.
• W3148102859 hasConcept C44249647 @default.
• W3148102859 hasConcept C71924100 @default.
• W3148102859 hasConcept C87355193 @default.
• W3148102859 hasConcept C99454951 @default.
• W3148102859 hasConceptScore W3148102859C121332964 @default.
• W3148102859 hasConceptScore W3148102859C126322002 @default.
• W3148102859 hasConceptScore W3148102859C142424586 @default.
• W3148102859 hasConceptScore W3148102859C167135981 @default.
• W3148102859 hasConceptScore W3148102859C203014093 @default.
• W3148102859 hasConceptScore W3148102859C207103383 @default.
• W3148102859 hasConceptScore W3148102859C2776409557 @default.
• W3148102859 hasConceptScore W3148102859C2777732132 @default.
• W3148102859 hasConceptScore W3148102859C2780727368 @default.
• W3148102859 hasConceptScore W3148102859C2908647359 @default.
• W3148102859 hasConceptScore W3148102859C3013748606 @default.
• W3148102859 hasConceptScore W3148102859C44249647 @default.
• W3148102859 hasConceptScore W3148102859C71924100 @default.
• W3148102859 hasConceptScore W3148102859C87355193 @default.

• next